Press release
Peripheral Drug-Eluting Balloons Market to Reach USD 1,844.3 Million by 2032, Reports Persistence Market Research
Peripheral Drug Eluting Balloons Market
The global peripheral drug eluting balloons (DEBs) market has witnessed steady expansion, fueled by advancements in interventional cardiology and the increasing prevalence of peripheral arterial disease (PAD). Valued at US$ 975.7 million in 2024, the market is projected to reach US$ 1,844.3 million by 2032, advancing at a robust CAGR of 8.6%. This growth underscores the rising adoption of minimally invasive treatment options for vascular diseases worldwide.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/27211
A key driver behind this momentum is the aging population, which is highly susceptible to cardiovascular complications, along with the rising prevalence of diabetes, obesity, and smoking-related vascular conditions. Among product categories, paclitaxel drug-coated balloons dominate the market, holding 47.8% share in 2024, owing to their proven efficacy in preventing restenosis. Geographically, North America leads the market, accounting for 36.2% of global sales in 2024, driven by advanced healthcare infrastructure, high disease prevalence, and strong R&D investments.
Key Highlights from the Report
✦ Market valued at US$ 975.7 million in 2024, projected to reach US$ 1,844.3 million by 2032
✦ Paclitaxel drug coating held a dominant 47.8% share of the market in 2024
✦ Peripheral DEBs accounted for 17.2% revenue share of the global peripheral vascular devices market
✦ North America remains the leading region, contributing 36.2% of market share
✦ U.S. market driven by high prevalence of PAD and strong device innovation
✦ China and Germany emerging as lucrative markets due to reforms and infrastructure growth
Market Segmentation
By Drug Coating: The market is segmented primarily into paclitaxel-coated and sirolimus-coated balloons. Paclitaxel coatings dominate due to their established effectiveness in reducing restenosis, while sirolimus-coated devices are gaining traction for their safety profile.
By Indication: Peripheral arterial disease accounts for the largest share, with 37.8% in 2024. This segment continues to expand as PAD incidence grows globally, linked to lifestyle changes and rising diabetes rates.
By End User: Hospitals remain the largest end-user segment, benefiting from advanced facilities, trained specialists, and greater access to reimbursement policies. Ambulatory surgical centers are increasingly adopting DEBs, driven by demand for minimally invasive outpatient care.
Read More In Detail: https://www.persistencemarketresearch.com/market-research/peripheral-drug-eluting-balloon-market.asp
Regional Insights
North America: With its advanced healthcare infrastructure and high prevalence of PAD, North America dominates the market. The U.S. alone accounts for more than one-third of global revenue, supported by strong adoption of innovative devices and favorable reimbursement.
Asia-Pacific: Rapidly growing healthcare expenditure and government reforms in countries such as China and India are propelling growth. China benefits from favorable reimbursement policies and collaborations with international medical device manufacturers.
🇪🇺 Europe: Germany leads the European market, driven by advanced healthcare infrastructure, widespread physician training, and increased awareness of peripheral artery disease treatment options.
Latin America & Middle East: Though smaller in market share, these regions are witnessing rising demand due to improving healthcare access and growing prevalence of cardiovascular diseases.
Market Drivers
The primary driver of the peripheral DEBs market is the increasing prevalence of peripheral artery disease (PAD), which affects millions globally. Rising healthcare awareness, coupled with lifestyle factors such as smoking, pollution, and sedentary habits, is contributing significantly to the disease burden. In addition, the shift towards minimally invasive treatment options enhances patient recovery times and reduces procedural risks, driving the adoption of DEBs. Growing demand from aging populations worldwide further accelerates market expansion.
Market Restraints
One of the most significant restraints is the high cost of drug-eluting balloons compared to traditional angioplasty or stents. Budgetary limitations in developing regions, combined with limited reimbursement in certain countries, can deter widespread adoption. Moreover, the lack of long-term clinical evidence and limited large-scale trials undermine healthcare providers' confidence in adopting DEBs as a standard treatment option.
Market Opportunities
Emerging economies present vast opportunities for manufacturers. Increasing healthcare investments in low- and middle-income countries, rising government support for advanced cardiovascular treatments, and collaborative R&D ventures open new avenues. Additionally, innovations in drug coatings beyond paclitaxel, such as sirolimus, are likely to diversify treatment options, improving efficacy and expanding the global market.
Do You Have Any Query Or Specific Requirement? Request Customization of Report: https://www.persistencemarketresearch.com/request-customization/27211
Reasons to Buy the Report
✔ Gain detailed insights into current and future market dynamics
✔ Understand regional growth patterns and emerging markets
✔ Identify leading drug coatings, indications, and end-user trends
✔ Assess competitive strategies and recent innovations by key players
✔ Support strategic decision-making with in-depth market forecasts
Company Insights
• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical Inc.
• MicroPort Scientific Corporation (EndovastecTM)
• Medtronic Plc.
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Becton, Dickinson and Company
• W. L. Gore & Associates Inc.
• Getinge AB
• Terumo Corp
• Kyoto Medical Planning Co Ltd
• iVascular S.L.U
• AMG International GmbH
Recent Developments
In August 2022, BD initiated a first-in-human trial to evaluate sirolimus-coated balloons for treating peripheral arterial disease in the femoropopliteal arteries.
In June 2018, Terumo received CE approval for its Kanshas drug-coated balloon catheter, designed for treating lower extremity peripheral arterial disease.
Conclusion
The peripheral drug eluting balloons market is set for robust growth, supported by rising prevalence of PAD, increasing healthcare investments, and strong innovation in drug coatings. While cost and limited long-term data remain hurdles, opportunities in emerging economies and ongoing clinical advancements are expected to sustain demand. With the market projected to grow at a CAGR of 8.6% from 2025 to 2032, stakeholders including manufacturers, healthcare providers, and investors can look forward to significant expansion in this transformative medical device segment.
Related Reports:
https://www.persistencemarketresearch.com/market-research/dermatology-imaging-market.asp
https://www.persistencemarketresearch.com/market-research/endocrine-testing-market.asp
https://www.persistencemarketresearch.com/market-research/personalized-medicine-biomarker-market.asp
https://www.persistencemarketresearch.com/market-research/clinical-laboratory-services-market.asp
https://www.persistencemarketresearch.com/market-research/swine-autogenous-vaccines-market.asp
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peripheral Drug-Eluting Balloons Market to Reach USD 1,844.3 Million by 2032, Reports Persistence Market Research here
News-ID: 4148964 • Views: …
More Releases from Persistence Market Research
North America Household Washer and Dryer Market Set to Reach US$ 22.2 Bn by 2032 …
The North America household washer and dryer market is poised for steady growth, supported by rising demand for smart home appliances, changing lifestyle patterns, and technological enhancements in laundry equipment. The market is projected to reach US$ 17.3 billion in 2025, and with a CAGR of 3.5% from 2025 to 2032, it is expected to climb to US$ 22.2 billion by 2032.
➤ Download Your Free Sample & Explore Key Insights:…
Indoor Plants Market to Grow at 5.4% CAGR Through 2032 as Demand for Green Inter …
The global indoor plants market is poised for sustained expansion over the next several years. According to Persistence Market Research, the market is projected to grow from US$ 22.6 billion in 2025 to US$ 32.7 billion by 2032, reflecting a CAGR of 5.4% during the forecast period. This upward trajectory underscores the increasing consumer shift toward wellness-driven living, biophilic interiors, and nature-connected home environments.
➤ Download Your Free Sample & Explore…
UV Disinfection Equipment Market Poised for Strong 16.3% CAGR Growth Through 203 …
The global UV disinfection equipment market is poised for remarkable expansion over the next decade. Industry estimates indicate that the market will be valued at US$ 17.0 billion in 2025 and is projected to surge to US$ 48.9 billion by 2032, registering a powerful CAGR of 16.3% between 2025 and 2032. This accelerated growth reflects heightened global focus on safety, hygiene, water quality, and chemical-free disinfection methods across both residential…
Surfing Apparel and Accessories Market Booms at 5.5% CAGR Through 2031, Reports …
The global surfing apparel and accessories market is set for steady expansion over the next several years. According to industry estimates, the market is anticipated to rise from US$ 9.5 billion in 2024 to US$ 14.1 billion by 2031, reflecting a healthy CAGR of 5.5% during the forecast period. This upward trajectory highlights the increasing global appeal of surfing as both a sport and a lifestyle.
➤ Download Your Free Sample…
More Releases for Peripheral
Key Trends Reshaping the Peripheral Arterial Disease Market: Innovative Shockwav …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Peripheral Arterial Disease Market Size Growth Forecast: What to Expect by 2025?
The overall valuation of the peripheral arterial disease sector has seen substantial expansion lately, projected to climb from $4.36 billion recorded in 2024 to reach $4.74 billion by 2025, reflecting an 8.7% compound annual growth rate over…
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive…
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of…
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorder…
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.
Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533
The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a…
